Furthermore, increasing evidence indicates that AKT3 can be an oncogene in many cancers, including osteosarcoma [10], colorectal cancer [11], prostate cancer [12], and breast cancer [13]. This evidence concerns the gene AKT3 and prostate carcinoma.